Published by Frank Prenesti on 9th January 2024
(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).
URL: http://www.digitallook.com/dl/news/story/34012260/...